This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, eHealth) (353) Pulmonology, COPD (143) Respiratory Medicine (83)

Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/52553, first published .
Design and Rationale of Cytokine Filtration in Lung Transplantation (GLUSorb): Protocol for a Multicenter Clinical Randomized Controlled Trial

Design and Rationale of Cytokine Filtration in Lung Transplantation (GLUSorb): Protocol for a Multicenter Clinical Randomized Controlled Trial

Design and Rationale of Cytokine Filtration in Lung Transplantation (GLUSorb): Protocol for a Multicenter Clinical Randomized Controlled Trial

Authors of this article:

Sandra Lindstedt1 Author Orcid Image ;   Martin Silverborn2 Author Orcid Image ;   Lukas Lannemyr2 Author Orcid Image ;   Leif Pierre1 Author Orcid Image ;   Hillevi Larsson1 Author Orcid Image ;   Edgars Grins1 Author Orcid Image ;   Snejana Hyllen1 Author Orcid Image ;   Goran Dellgren2 Author Orcid Image ;   Jesper Magnusson2 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.